Recent Interventions for Acute Suicidality Delivered in the Emergency Department: A Scoping Review.

A scoping review of nine studies identified interventions for treating acute suicidality in emergency departments (EDs) that were tested between 2013 and 2023. Four studies tested a single dose of ketamine, three tested brief psychosocial interventions (two with follow-up care), and two tested motivational interviewing. The interventions with the strongest evidence and best fit for the ED environment were ketamine and Crisis Response Planning (CRP). However, the included studies had small sample sizes (average 57 participants), and there is currently insufficient evidence to conclude that these interventions are effective and well-suited for routine ED use. Further research is needed.

Study at a glance

Abstract

Suicidality is a growing problem in the US, and the emergency department (ED) is often the front line for the management and effective treatment of acutely suicidal patients. There is a dearth of interventions that emergency physicians may use to manage and effectively treat acutely suicidal patients. To the extent that recently described interventions are available for ED personnel, no review has been conducted to identify them. This scoping review is intended to fill this gap by systematically reviewing the literature to identify recently described interventions that can be administered in the ED to reduce symptoms and stabilize patients. We conducted a search of PubMed, SCOPUS, and CINAHL in January 2024 to identify papers published between 2013-2023 for original research trialing recent interventions for the effective treatment of suicidality in the ED. We assessed 16 full-text articles for eligibility, and nine met inclusion criteria. Included studies were evaluated for features and characteristics, the fit of the intervention to the ED environment, and interventional efficacy. Four studies assessed the efficacy of a single dose of the anesthetic/analgesic agent ketamine. Three studies assessed the efficacy of a brief psychosocial intervention delivered in the ED, two of which paired this intervention with the provision of follow-up care (postcard contact and referral assistance/case management, respectively). The remaining two studies trialed a brief, motivational interviewing-based intervention. Included studies had strong experimental designs (randomized controlled trials) but small sample sizes (average 57). Among the interventions represented across these nine studies, a single dose of ketamine and the brief psychosocial intervention Crisis Response Planning (CRP) show promise as ED-appropriate interventions for suicidality. Ketamine and CRP demonstrated the strongest fit to the ED environment and most robust efficacy findings. This review identified one drug (ketamine) and four unique psychological/behavioral interventions that have been used to treat acute suicidality in the ED. There is currently insufficient evidence to suggest that these interventions will prove efficacious and well-suited to be delivered in the ED environment. Future studies should continue to test these interventions in the ED setting to determine their feasibility and efficacy.